Naropin: safety and efficacy not established in children under 1 year of age.
D016907:Adverse Drug Reaction Reporting Systems; D000367:Age Factors; D000577:Amides / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000009:adverse effects*; D001049:Apnea / Q000139:chemically induced; D001919:Bradycardia / Q000139:chemically induced; D017277:Drug Approval; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000077212:Ropivacaine; D012449:Safety; D013019:South Africa
D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine